This inventor holds 32 USPTO granted patents and 1 EPO patent, primarily in Carbapenem Chemistry. Top assignees: Meiji Seika Kaisha, Ltd., Meiji Seika Kabushiki Kaisha, Sagami Chemical Research Center. Active years: 1984-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Yokohama-shi, Kanagawa-ken, JP (1988)
- Kawasaki, JP (1989 - 1990)
- Tokyo, JP (2008)
- Yokohama, JP (1984 - 2009)
- Kanagawa-ken, JP (1997 - 2009)
- Tokyo-To, JP (2010)
Company Filing History:
24 out of 382 
7 out of 32 
1 out of 191 Years Active: 1984-2010
Areas of Expertise:
Title: Kunio Atsumi: Innovator in Antimicrobial Compounds
Introduction: Kunio Atsumi, based in Kanagawa-ken, Japan, is an accomplished inventor with a significant portfolio of 32 patents. His work primarily focuses on the development of innovative compounds, particularly in the field of antimicrobial agents. Atsumi's contributions have had a substantial impact on the pharmaceutical industry, enhancing the effectiveness of treatments against various infectious diseases.
Latest Patents: Atsumi's most recent patents showcase his expertise in creating advanced compounds. One notable patent is for imidazothiazole derivatives and the process for their production. This invention involves compounds that utilize halogen atoms and specific alkyloxy groups, offering a synthetic pathway to produce carbapenem derivatives with potent antimicrobial properties efficiently and cost-effectively. Another significant patent involves intermediates of 2-substituted carbapenem derivatives and their production process. Similar to the previous innovation, this patent emphasizes the safe and economical creation of carbapenem derivatives with a wide spectrum of antimicrobial activity.
Career Highlights: Throughout his career, Kunio Atsumi has worked with prominent companies in the pharmaceutical sector. Notably, he has been associated with Meiji Seika Kaisha, Ltd. and Meiji Seika Kabushiki Kaisha, where he collaborated with other talented professionals, further enhancing his innovative capabilities.
Collaborations: Atsumi has collaborated with esteemed colleagues, including Katsuyoshi Iwamatsu and Kazuhiro Aihara. These partnerships have played a crucial role in advancing his research and development efforts, facilitating the successful realization of his patented inventions.
Conclusion: Kunio Atsumi's impressive portfolio of patents demonstrates his dedication to innovation in the field of antimicrobial compounds. His contributions not only highlight his inventiveness but also underscore the importance of collaboration in achieving significant advancements in medical science. As his work continues to evolve, Atsumi remains a key figure in the quest for effective treatments against infectious diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile